共查询到20条相似文献,搜索用时 15 毫秒
1.
OBJECTIVE: To determine if behavioral symptoms detected at initial evaluation relate to cognitive or functional status or survival time in Alzheimer's disease (AD) patients. method: Review, in 100 cases of autopsy-proven AD, of the relationship of behavioral symptoms detected at initial evaluation to cognitive and global function measures and survival time. RESULTS: Behavioral symptoms had occurred in 74% of patients, including apathy (51%), hallucinations (25%), delusions (20%) and depressed mood (6.6%). Verbal aggression was common (36.8%); physical aggression less so (17%). The symptomatic group was more functionally (but not cognitively) impaired and had shorter median survival time (8 years: 95% CI: 7-9 years vs. 10 years: 95% CI: 8-12 years; P = 0.002) than the asymptomatic group. The presence of any one symptom at initial evaluation accounted for 6.1% of the variance in duration of illness. CONCLUSION: Presence of behavioral symptoms at initial evaluation of AD patients is associated with greater functional impairment and shorter survival time. 相似文献
2.
Tractenberg RE Gamst A Weiner MF Koss E Thomas RG Teri L Thal L 《International journal of geriatric psychiatry》2001,16(9):886-891
This study describes two well-characterized groups of Alzheimer's disease (AD) patients with similar levels of cognitive functioning, but with different overall behavioral disturbance levels. We sought to determine the nature of this difference-whether AD patients with higher levels of behavioral disturbance (n = 148) differ from less disturbed AD patients (n = 235) in terms of (a) the range of symptoms exhibited, (b) the frequency of occurrence of these symptoms, or (c) both of these. We defined and operationalized 'diversity of behaviors' and 'frequency' with respect to the item-level responses on the Cohen-Mansfield agitation inventory (CMAI). We found that, in these two samples of AD patients, differences occurred in the frequency of 10 out of 21 behaviors, rather than in a variety of endorsed behaviors. These 10 behaviors, observed at different frequencies in both groups, may be useful for monitoring change in studies of drugs or behavioral interventions for behavioral disturbance in persons with AD. 相似文献
3.
Toyota Y Ikeda M Shinagawa S Matsumoto T Matsumoto N Hokoishi K Fukuhara R Ishikawa T Mori T Adachi H Komori K Tanabe H 《International journal of geriatric psychiatry》2007,22(9):896-901
BACKGROUND: When comparing with early-onset Alzheimer's disease (EO-AD) and late-onset Alzheimer's disease (LO-AD), some symptomatological differences in clinical features can be seen between them. Rapid progression, more severe language problems or visuospatial dysfunction occur more often in EO-AD patients. However, there have been very few reports about the differences in behavioral and psychological symptoms between these two groups. AIM: The aim of this study was to demonstrate the differences in behavioral symptoms between EO-AD and LO-AD groups. METHOD: Three hundred and seven consecutive outpatients with AD were put into an EO-AD group (46 patients) or a LO-AD group (261 patients). Comprehensive assessment batteries, including the Neuropsychiatric Inventory (NPI), were administered at the first medical assessment. RESULTS: Significant differences were found between the EO-AD and LO-AD groups in terms of NPI total score (EO-AD: 10.3 +/- 10.9, LO-AD: 17.8 +/- 17.0, p = 0.004) and number of patients who experienced each NPI subscale score (delusion; EO-AD: 13.0%, LO-AD: 50.6%, p < 0.001). There were no differences in cognitive functions or dementia severity between two groups. CONCLUSION: In EO-AD, behavioral and psychological symptoms are relatively fewer than LO-AD at the first medical assessment. Copyright (c) 2007 John Wiley & Sons, Ltd. 相似文献
4.
Characteristics of behavioral and psychological symptoms in the oldest patients with Alzheimer's disease 总被引:2,自引:1,他引:1
Nobuo FURUTA Masaru MIMURA Hiroshi ISONO Yuichi SUGAI Kunitoshi KAMIJIMA 《Psychogeriatrics》2004,4(1):11-16
Background: Advancing age increases the risk of developing dementia. Recent studies have clarified characteristic cognitive changes in very old patients with dementia. Although non‐cognitive symptoms are frequent in dementia, relatively little attention has been paid to the nature of behavioral and psychological symptoms of dementia (BPSD). Methods: A retrospective review of a database was performed to compare 27 very old patients with Alzheimer's disease (AD) (onset age ≥ 85) with 162 less old patients (onset age < 85). Cognitive decline, ability to carry out activities of daily living (ADL), and overall severity were rated. BPSD were evaluated using a 16‐item questionnaire to the compare frequency of each symptom between old and very old groups. Results: Cognitive decline was equivocal in both old and very old groups. In contrast, very old patients were more impaired in ADL, and BPSD were more frequent in very old patients. Delusions, irritability, and delusional misidentification syndrome were frequent in both groups, but were more prominent in very old patients. Behavioral abnormalities such as excitement, delirium, reversed diurnal rhythm, and wandering were not prominent in old patients, but were frequent in very old patients. Conclusions: Very old AD patients presented more frequent BPSD than old AD patients. Troublesome behavioral abnormalities particularly prominent in the older patients might represent a heavy burden for caregivers. 相似文献
5.
阿尔茨海默病行为和精神症状及相关因素研究 总被引:4,自引:0,他引:4
目的 探讨阿尔茨海默病(AD)行为和精神症状(BPSD)的特点及其相关因素.方法 对符合美国精神障碍诊断和统计手册第四版修正版(DSM-IV-R)诊断标准的46例住院AD患者,进行一般资料调查,评定简易智力状态检查(MMSE)、临床痴呆评定表(CDR)、AD病理行为评分表(BEHAVE-AD)及日常生活能力量表(ADL),分析BPSD症状特点及与有关因素的关系.结果 BPSD的发生率为100%,其中以行为紊乱发生率最高(91.3%).幻觉发生率以重度AD最高(47.6%),MMSE分值与BEHAVE-AD幻觉分量表分呈负相关(P<0.05).患者年龄与BEHAVE-AD行为紊乱、日夜节律紊乱分量表分和总分呈负相关(P<0.05或P<0.01).ADL分值与BEHAVE-AD幻觉、行为紊乱、日夜节律紊乱分量表分及总分呈正相关(P<0.05).结论 住院AD患者BPSD的发生率非常高,应引起临床足够的重视.幻觉的出现可作为AD痴呆严重度的预警因素.AD患者BPSD可能与年龄和日常生活能力有关. 相似文献
6.
目的探讨阿尔茨海默病痴呆患者的行为和精神症状。方法选取本院2011年5月至2015年5月诊治的痴呆性老年患者80例,其中血管性痴呆(VD)患者40例为VD组,阿尔茨海默病(AD)患者40例为AD组,均行AD行为评分表(Behave-AD)评定,比较两组患者的行为和精神症状。结果 AD组患者偏执和妄想发生率、行为紊乱发生率、攻击行为发生率、焦虑和恐惧发生率均明显高于VD组,AD组患者偏执和妄想评分、行为紊乱评分、攻击行为评分、焦虑和恐惧评分、总评分均明显高于VD组,差异有统计学意义(P0.05)。AD组患者幻觉发生率高于VD组,AD组患者日间节律紊乱发生率、情感障碍发生率均低于VD组,AD组患者幻觉评分高于VD组,AD组患者日间节律紊乱评分、情感障碍评分均低于VD组,但差异无统计学意义(P0.05)。结论 AD患者偏执和妄想、行为紊乱、攻击行为、焦虑和恐惧等病症较为严重,其发生机制可能与AD患者存在较明显的额-枕叶萎缩有关。 相似文献
7.
8.
Relationship of behavioral and psychological symptoms to cognitive impairment and functional status in Alzheimer's disease 总被引:2,自引:0,他引:2
Harwood DG Barker WW Ownby RL Duara R 《International journal of geriatric psychiatry》2000,15(5):393-400
OBJECTIVE: This cross-sectional study examined the relationship of behavioral and psychological symptoms to cognitive and functional impairment in Alzheimer's disease (AD). DESIGN: One hundred and fourteen patients were evaluated consecutively at a university-affiliated outpatient memory disorders clinic and diagnosed with possible or probable Alzheimer's disease (AD) according to NINCDS-ADRDA criteria. Subjects were assessed with the Behavioral Pathology in Alzheimer's Disease Scale (BEHAVE-AD), Revised Memory and Behavior Problem Checklist (RMBPC), Blessed Dementia Scale (BDS), and Mini-Mental State Examination (MMSE). RESULTS: Several symptoms of behavioral pathology showed associations with MMSE scores, including activity disturbances, delusions, and hallucinations. After controlling for the variance associated with the MMSE, activity disturbances, diurnal disturbances, delusions, and hallucinations were linked with BDS scores. CONCLUSIONS: The results suggest that some non-cognitive symptoms may be related to the neurobiologic mechanisms underlying the increased cognitive dysfunction in AD. Specific symptoms of behavioral pathology may also impact a patient's ability to perform important self-maintenance behaviors. 相似文献
9.
Atsushi HAMURO Hiroshi ISONO Yuichi SUGAI Masaru MIMURA Kunitoshi KAMIJIMA 《Psychogeriatrics》2008,8(1):8-11
Background: The proportion of the population aged 85 years and older has increased rapidly in Japan, reaching 2.5 million (1.99%) in 2002. Under these circumstances, the number of dementia patients increases annually. However, few studies have focused on Alzheimer's disease (AD) with an age at onset older than 85 years (oldest old AD). The aims of the present study were to determine the prevalence of the behavioral and psychological symptoms of dementia (BPSD) in patients with oldest old AD compared with those with young old AD. Methods: Fifty‐eight untreated AD patients were divided into two groups: young old AD patients (age at onset between 65 and 70 years; n = 28) and oldest old AD patients (age at onset 85 years or older; n = 30). Then, BPSD were compared between the two groups. Results: There were significant differences in the frequencies of hallucinations (χ2 = 7.43; P = 0.011) and delusional misidentification syndrome (DMS; χ2 = 7.26; P = 0.011) between the two groups. Conclusions: The results of the present study suggest that aging may play a part in the occurrence of hallucinations and DMS in oldest old AD patients. 相似文献
10.
目的探讨阿尔茨海默病(Alzheimer's disease,AD)患者精神行为症状(behavioral and psychologicalsymptoms of dementia,BPSD)复发的危险因素和特征。方法收集102例以BPSD发作就诊的AD患者,在BPSD发作控制后进行12个月的随访。BPSD的严重程度应用神经精神量表(neuropsychiatric inventory,NPI)评估,并将NPI因子归类为情感障碍、精神病性症状和失控行为3个症状群。分析BPSD复发与先前发作的特征,复发与患者人口学资料、发病年龄、病程、认知功能、日常生活能力、基线NPI评分等因素的关系。结果 12个月内44.1%(45/102)的患者BPSD复发。Cox回归分析显示,环境改变(RR=5.42,P<0.05)、未维持服药(RR=3.13,P<0.05)和上次发作NPI评分高(RR=1.06,P<0.05)增加BPSD复发的风险;两次BPSD发作之间的症状数相关(r=0.93,P<0.05),而情感障碍评分也相关(r=0.79,P<0.05);复发的NPI总分和精神病性症状评分均低于上次发作[(18.29±2.0... 相似文献
11.
奎硫平治疗阿尔茨海默病精神行为症状对照研究 总被引:1,自引:0,他引:1
目的:比较奎硫平与利培酮对阿尔茨海默病(AD)患者精神行为症状(BPSD)的疗效和安全性。方法:80例伴精神行为症状的AD患者随机分为两组,分别给予奎硫平与利培酮治疗,疗程6周。采用痴呆病理行为评定量表(BEHAVE-AD)、简易智力状态检查(MMSE)评定疗效;治疗中出现的症状量表(TESS)评定不良反应。结果:奎硫平组有效率85.0%;利培酮组有效率82.5%。奎硫平组不良反应低于利培酮组。结论:奎硫平与利培酮均能显著改善AD患者BPSD,奎硫平安全性更高。 相似文献
12.
《中风与神经疾病杂志》2019,(9):778-783
目的对比分析阿尔茨海默病(AD)和血管性认知障碍患者的精神行为症状特点及相关危险因素。方法回顾性分析2015年11月~2017年12月在吉林大学第一医院神经内科记忆门诊就诊的AD源性认知障碍患者447例和血管性认知障碍患者346例,对其进行神经心理学测试,根据临床痴呆评定量表(CDR)检测痴呆严重程度后分为4组(轻度认知功能障碍组、轻度痴呆组、中度痴呆组、重度痴呆组),进行神经精神量表(NPI)测试,结果再进行统计学分析。结果和Va D组相对比,AD组痴呆的精神行为症状总体症状发生率(66. 9%)高于Va D(58. 7%),差异有统计学意义(P <0. 05)。其中,AD组妄想(15. 2%)和异常运动发生率(13. 9%)均高于Va D组(9. 5%、7. 8%),有统计学意义(P <0. 05)。相同痴呆程度发病率比较中,中度和重度痴呆组AD的BPSD总体发生率(88. 0%,91. 2%)高于Va D(64. 3%,71. 4%),差异有统计学意义(P <0. 05)。相同痴呆程度下,AD和Va D的BPSD总体严重程度差异无统计学意义(P> 0. 05)。在中度痴呆组AD组的妄想、异常运动行为严重程度重于Va D,差异有统计学意义(P <0. 05)。BPSD组中有饮酒史者(32. 8%)多于非BPSD组(24. 5%),且差异有统计学意义(P <0. 05)。结论 AD和Va D的BPSD发生率均高,但AD组高于Va D组。其中妄想、异常运动行为更易发生在AD患者组。中重度痴呆的AD患者BPSD发生率均高于Va D患者。中度痴呆时,AD组妄想、异常运动行为的严重程度重于Va D。饮酒史是BPSD发生的独立危险因素。 相似文献
13.
Akira Monji Masashi Takita Takaaki Samejima Toshihiro Takaishi Kazuhito Hashimoto Hiroyuki Matsunaga Mariko Oda Yasuhisa Sumida Yoshito Mizoguchi Takahiro Kato Hideki Horikawa Shigenobu Kanba 《Progress in neuro-psychopharmacology & biological psychiatry》2009
Objective
The aim of this study was to investigate the effects of yokukansan (YKS) on the behavioral and psychological symptoms of dementia (BPSD) in elderly patients with Alzheimer's disease (AD).Methods
Fifteen patients with AD (mean age: 80.2 ± 4.0 years) participated in the study. The Mini-Mental State Examination (MMSE) was used for the assessment of cognitive function. BPSD were evaluated using the Neuropsychiatric Inventory (NPI). The Barthel Index was used for the assessment for the activities of daily living (ADL). The treatment with YKS along with sulpiride, a dopamine D2 selective antipsychotic, was performed for 12 weeks.Results
Fourteen patients completed the trial. After the 12 weeks of treatment with YKS, significant improvement of the mean NPI score was observed while no significant improvement was observed in the control group. The average dose of sulpiride at the end of the present study was less in the YKS group than in the control group. The MMSE results did not change either in the YKS group or in the control group. The Barthel Index did not significantly change either in the YKS group or in the control group. No serious adverse effects were noted.Conclusions
Twelve weeks of the YKS treatment significantly improved BPSD with less antipsychotics in elderly patients with AD. The YKS treatment did not cause any cognitive decline or ADL decline and no serious adverse effects were noted. The present study suggests that YKS is beneficial for the treatment of BPSD and that it can possibly reduce the doses of antipsychotics required for the treatment of BPSD. Further studies with larger patient populations using a double-blind placebo-controlled design should be performed. 相似文献14.
15.
M B Patterson A H Schnell R J Martin M F Mendez K A Smyth P J Whitehouse 《Journal of geriatric psychiatry and neurology》1990,3(1):21-30
Noncognitive behavioral symptoms occurring during the prior week were studied in 34 Alzheimer's disease (AD) patients and 21 spousal control subjects via caregiver and patient interviews using the Behavioral Pathology in Alzheimer's Disease Rating Scale and the Cornell Scale for Depression in Dementia. Delusional or paranoid features were reported in 13 subjects (38%) and hallucinations in six (18%); patients with these psychoticlike symptoms had lower scores on the Folstein's Mini-Mental State Examination. Other behavioral symptoms reported in AD patients included anxiety (50%) and activity disturbances (44%). Six AD subjects (18%) and two controls (10%) showed mild to moderate symptoms of depression; AD subjects were more likely than controls to show behavioral signs and symptoms of depression, but the two groups did not differ in terms of mood-related, cyclical, or physical signs and symptoms. 相似文献
16.
Kazunori Okahara Yasushi Ishida Yoshihito Hayashi Teruhiko Inoue Kazuhito Tsuruta Kouzou Takeuchi Hirofumi Yoshimuta Kouichirou Kiue Yoshimasa Ninomiya Jiro Kawano Kensei Yoshida Shouji Noda Seiichiro Tomita Masumi Fujimoto Jun Hosomi Yoshio Mitsuyama 《Progress in neuro-psychopharmacology & biological psychiatry》2010
Yokukansan (YKS) is used frequently against behavioral and psychological symptoms of dementia (BPSD) together with donepezil in patients with Alzheimer's disease (AD). Here, we investigated the efficacy and safety of YKS in patients with AD in a non-blinded, randomized, parallel-group comparison study. Patients who had at least one symptom score of four or more on the Neuropsychiatric Inventory (NPI) subscales were enrolled in the study. The subjects were randomly assigned to the YKS-treated group (YKS/donepezil combination therapy group) and the non-YKS-treated group (donepezil monotherapy group). TSUMURA Yokukansan (TJ-54, 7.5 g, t.i.d.) was administered in a four-week study treatment period. The subjects were evaluated twice at the start (Week 0) and completion (Week 4) of the study treatment in terms of NPI, Mini-Mental Status Examination (MMSE), Disability Assessment for Dementia (DAD), Zarit Burden Interview, and Self-rating Depression Scale (SDS). The efficacy analysis was performed in 29 patients (YKS-treated group) and 32 patients (non-YKS-treated group). The NPI total score improved significantly more in the YKS-treated group than in the non-YKS-treated group. In the NPI subscales of agitation/aggression and irritability/lability, the YKS-treated group showed significantly greater improvement than the non-YKS-treated group, but no statistically significant improvement was seen with YKS in the other subscales. There were no significant differences between the YKS-treated group and the non-YKS-treated group in MMSE, DAD, Zarit Burden Interview and SDS. No adverse reactions were noted in either group. The results of this study showed that YKS is safe and effective in the treatment of BPSD in AD patients. 相似文献
17.
18.
Chia‐Fen Tsai MD Shuu‐Jiun Wang MD Ling Zheng MD PhD Jong‐Ling Fuh MD 《Psychiatry and clinical neurosciences》2010,64(4):408-414
Aim: Alzheimer's disease (AD) is characterized by cognitive symptoms and behavioral symptoms, and their association is inconsistent. The aim of this study was to investigate the relationship between cognitive function and the changes in behavioral and psychological symptoms of dementia (BPSD) in patients with AD. Methods: A total of 101 patients with probable AD were enrolled (57 women and 44 men, mean age 77.6 ± 7.7 years). The Category Verbal Fluency Test (CVFT), the Mini‐Mental State Examination (MMSE), the Constructional Praxis Test, the Delayed Word Recall Test, the Clinical Dementia Rating Scale, and the Neuropsychiatry Inventory (NPI) were administered at baseline. The NPI was reassessed with a median follow‐up duration of 10 months (range 6–18 months). The change in the NPI scores was defined as the end‐point score of the NPI minus the initial one. The associations between the changes in NPI total score, its four subdomains (hyperactivity, psychosis, affection, and apathy), and cognitive function were examined using multivariate linear models. The results were adjusted for confounders including demographics, baseline NPI, and duration of follow up. Results: The mean MMSE was 18.6 ± 5.6, the CVFT score was 7.1 ± 3.9, and the NPI score was 10.9 ± 13.8. Regression analyses found that the CVFT score (β = ?0.32, P = 0.004) was significantly associated with the change in NPI score, but not the MMSE, the Delayed Word Recall score, or the Constructional Praxis score. The CVFT score was significantly associated with changes in the psychosis subdomain (β = ?0.34, P = 0.001), but not the other subdomains. Conclusions: Our study showed that CVFT was predictive of the changes in behavior disturbance in patients with AD, particularly in the psychosis domain. 相似文献
19.
Kimiko KONISHI Koji HORI Tatsuro ODA Itaru TOMINAGA Toshiyasu ASAOKA Mitsugu HACHISU Toshiaki SHIBASAKI 《Psychogeriatrics》2009,9(1):11-16
Aim: The aim of the present study was to evaluate the relationship between aging and the behavioral and psychological symptoms of dementia (BPSD) in patients with Alzheimer's disease (AD).
Methods: Eligible subjects were consecutively referred AD patients with BPSD. According to patient age at the time of the test, the AD patient group ( n = 79, whole AD group (WADG)) was divided into two groups: a relative older group (OG) in the whole AD group (WAD) (age at the time of test was 81 years or more, n = 40) and a relative younger group (YG) in the WAD (age at the time of test was below 81 years, n = 39). A comparison was made of the demographic data (sex difference, educational level and severity of dementia), cognitive functions and BPSD between the groups. BPSD was evaluated using the Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD). The factor analysis of BPSD was conducted in the WADG as well as in the OG and YG.
Results: Sex difference, educational level, severity of dementia and cognitive functions were not different; however, the total score of the BEHAVE-AD symptom domain in diurnal rhythm was significantly higher in the OG than in the YG (Student's t -test: P < 0.05). Factor analysis showed that psychosis was the first factor in the OG, but was the third factor in the YG and that the psychotic symptoms were caused by anxieties and phobias in the OG.
Conclusion: From these results, we found that the effects of aging on the BPSD in AD were characterized by diurnal rhythm disturbance and psychosis. 相似文献
Methods: Eligible subjects were consecutively referred AD patients with BPSD. According to patient age at the time of the test, the AD patient group ( n = 79, whole AD group (WADG)) was divided into two groups: a relative older group (OG) in the whole AD group (WAD) (age at the time of test was 81 years or more, n = 40) and a relative younger group (YG) in the WAD (age at the time of test was below 81 years, n = 39). A comparison was made of the demographic data (sex difference, educational level and severity of dementia), cognitive functions and BPSD between the groups. BPSD was evaluated using the Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD). The factor analysis of BPSD was conducted in the WADG as well as in the OG and YG.
Results: Sex difference, educational level, severity of dementia and cognitive functions were not different; however, the total score of the BEHAVE-AD symptom domain in diurnal rhythm was significantly higher in the OG than in the YG (Student's t -test: P < 0.05). Factor analysis showed that psychosis was the first factor in the OG, but was the third factor in the YG and that the psychotic symptoms were caused by anxieties and phobias in the OG.
Conclusion: From these results, we found that the effects of aging on the BPSD in AD were characterized by diurnal rhythm disturbance and psychosis. 相似文献
20.
Moran M Walsh C Lynch A Coen RF Coakley D Lawlor BA 《International journal of geriatric psychiatry》2004,19(4):359-364
OBJECTIVES: Behavioural and psychological symptoms of dementia (BPSD) are common in Alzheimer's disease (AD), and are associated with significant distress for patient and carer. Certain behavioural and psychological symptoms have been associated with each other, leading to the suggestion that differences in symptom patterns among patients with AD may represent different syndromes within AD. The purpose of this study is to see if patients with AD could be meaningfully classified into syndromes, based on the relationships between their BPSD. METHODOLOGY: The sample was recruited through a memory clinic. Two hundred and forty first visit patients with a diagnosis of very mild to mild AD were included. BPSD were assessed using the BEHAVE-AD. Latent class analysis was used to assess for different classes or groups of patients within the sample, based on their behavioural and psychological symptoms. RESULTS: Three classes were identified; Class 1 with a low prevalence of behavioural and psychological symptoms; Class 2 an anxiety/depressive symptom class and Class 3 an aggressive symptom class. CONCLUSIONS: The three classes (or groups) of patients obtained by LCA in this sample may be explained by a 'latent', as yet, unidentified factor. Further research is required to determine if these classes are stable over time, and to identify possible latent variables. 相似文献